Open AccessThe pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis
Author(s) -
Samir K. Gupta,
Susan L. Rosenkranz,
Yoninah Cramer,
Susan L. Koletar,
Lynda A. Szczech,
Valerianna Amorosa,
Stephen D. Hall
Publication year - 2008
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32830e011f
Subject(s) - cmin , lopinavir , lopinavir/ritonavir , efavirenz , pharmacokinetics , ritonavir , medicine , cmax , hemodialysis , geometric mean , confidence interval , pharmacology , gastroenterology , human immunodeficiency virus (hiv) , viral load , virology , antiretroviral therapy , mathematics , statistics
To evaluate the pharmacokinetics and pharmacogenomics of efavirenz (EFV) and lopinavir/ritonavir (LPV/RTV) in HIV-infected persons requiring hemodialysis.